Study to Assess the Efficacy and Safety of Liraglutide in the Treatment of Type 2 Diabetes

PHASE3UnknownINTERVENTIONAL
Enrollment

424

Participants

Timeline

Start Date

April 29, 2020

Primary Completion Date

December 1, 2021

Study Completion Date

December 2, 2021

Conditions
Type 2 Diabetes
Interventions
DRUG

Victoza®.

Patients will receive Victoza®. Both products will be provided as pen-injector.

DRUG

Metformin Hydrochloride

Patients who were receiving metformin prior to study will continue to receive it during the study.

DRUG

TQZ2451

Patients will receive TQZ2451.Both products will be provided as pen-injector.

Trial Locations (46)

116000

NOT_YET_RECRUITING

Dalian Municipal Central Hospital Affiliated of Dalian Medical University, Dalian

130000

RECRUITING

Affiliated Hospital of Changchun University of Chinese Medicine, Changchun

RECRUITING

Jilin Province FAW General Hospital, Changchun

RECRUITING

The Second Hospital of Jilin University, Changchun

134000

RECRUITING

Meihekou Central Hospital, Tonghua

150000

RECRUITING

The Fourth Affiliated Hospital of Harbin Medical University, Harbin

NOT_YET_RECRUITING

The Second Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin

200000

RECRUITING

Shanghai Pudong Hospital, Shanghai

210000

RECRUITING

Nanjing Drum Tower Hospital, Nanjing

RECRUITING

Nanjing Jiangning Hospital, Nanjing

221000

RECRUITING

Xuzhou Third People's Hospital, Xuzhou

222000

NOT_YET_RECRUITING

The Second People's Hospital of Lianyungang, Lianyungang

230000

NOT_YET_RECRUITING

The Second Hospital of Anhui Medical University, Hefei

NOT_YET_RECRUITING

The Second People's Hospital of Heifei, Hefei

241000

RECRUITING

Yijishan Hospital of Wannan Medical College, Wuhu

243000

RECRUITING

Ma'anshan People's Hospital, Ma’anshan

250000

RECRUITING

Jinan Central Hospital, Jinan

261000

NOT_YET_RECRUITING

Weifang Traditional Chinese Hospital, Weifang

300000

RECRUITING

General Hospital of Tianjin Medical University, Tianjin

NOT_YET_RECRUITING

Tianjin First Central Hospital, Tianjin

310000

NOT_YET_RECRUITING

Zhejiang Provincial People's Hospital, Hangzhou

318000

NOT_YET_RECRUITING

Taizhou First People's Hospital, Taizhou

330000

NOT_YET_RECRUITING

Nanchang First Hospital, Nanchang

400000

RECRUITING

The First Affiliated Hospital of Chongqing Medical University, Chongqing

RECRUITING

The Ninth People's Hospital of Chongqing, Chongqing

RECRUITING

The Second Affiliated Hospital of Chongqing Medical University, Chongqing

430000

NOT_YET_RECRUITING

The Third People's Hospital of Hebei, Wuhan

450000

RECRUITING

People's Hospital of Zhengzhou, Zhengzhou

453000

RECRUITING

Xinxiang Central Hospital, Xinxiang

471000

RECRUITING

The First Affiliated Hospital of Henan University of Science and Technology, Luoyang

524000

RECRUITING

Affiliated Hospital of Guangdong Medical University, Zhanjiang

530000

RECRUITING

The First People's Hospital of Nanning, Nanning

545000

RECRUITING

Liuzhou People's Hospital, Liuzhou

550000

RECRUITING

The Affiliated Hospital of Guizhou Medical University, Guiyang

650000

RECRUITING

First Affiliated Hospital of Kunming Medical University, Kunming

710000

NOT_YET_RECRUITING

The First Affiliated Hospital of The Fourth Military Medical University, Xian

RECRUITING

The Second Affiliated Hospital of Xi'an Jiaotong University (Xibei Hospital), Xian

NOT_YET_RECRUITING

The First Affiliated Hospital of Xi'an Jiaotong Univesity, Xi’an

750000

RECRUITING

People's Hospital of Ningxia Hui Autonomous Region, Yinchuan

050000

RECRUITING

The Third Hospital of Hebei Medical University, Shijiazhuang

046000

RECRUITING

Changzhi People's Hospital, Changzhi

RECRUITING

Peace Hospital Affiliated to Changzhi Medical College, Changzhi

048000

RECRUITING

Jincheng General Hospital, Jincheng

030000

RECRUITING

Second Hospital of Shanxi Medical University, Taiyuan

RECRUITING

Shanxi Provincial People's Hospital, Taiyuan

044000

RECRUITING

Yuncheng Central Hospital, Yuncheng

All Listed Sponsors
lead

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

INDUSTRY